Escalating intravenous methotrexate improves event-free survival in children with standard-risk acute lymphoblastic leukemia: a report from the Children's Oncology GroupYousif Matloub, Paul S. Gaynon, Bruce Bostrom et al.|Blood|2011Cited by 148
A comparison of neurocognitive functioning in children previously randomized to dexamethasone or prednisone in the treatment of childhood acute lymphoblastic leukemiaNina S. Kadan‐Lottick, Joseph P. Neglia, Pim Brouwers et al.|Blood|2009Cited by 79
Comparison of Neurocognitive Functioning in Children Previously Randomly Assigned to Intrathecal Methotrexate Compared With Triple Intrathecal Therapy for the Treatment of Childhood Acute Lymphoblastic LeukemiaNina S. Kadan‐Lottick, Joseph P. Neglia, Thomas A. Kaleita et al.|Journal of Clinical Oncology|2009Cited by 68
Survivors of standard risk acute lymphoblastic leukemia do not have increased risk for overweight and obesity compared to non‐cancer peers: A report from the Children's Oncology GroupSusan Lindemulder, Nina S. Kadan‐Lottick, Linda C. Stork et al.|Pediatric Blood & Cancer|2015Cited by 40
Excellent long-term survival of children with Down syndrome and standard-risk ALL: a report from the Children’s Oncology GroupYousif Matloub, Paul S. Gaynon, Karen R. Rabin et al.|Blood Advances|2019Cited by 36